The test MRSA and MSSA directly from blood culture samples in about one hour, compared to between 48 and 72 hours with other methods, the company said.
Researchers found that mutations in this gene increased the risk of chronic obstructive pulmonary disease, bone marrow failure, and other conditions.
The companion test will let doctors identify the best treatment for CLL patients with 17p deletions, a subset that has historically lacked therapeutic options.
The partners will jointly market ASI's imaging platforms with Agilent FISH products to help customers create automated workflows.
The new system emphasizes the importance of tumor biology as an important prognostic indicator for women who undergo neoadjuvant therapy, the researchers said.
Using genomic data for pediatric low-grade gliomas, researchers uncovered a MYB-QKI fusion that appears to drive angiocentric glioma development.
The firm's cytogenetic media, immunohistochemistry products, and fish probes have been certified for marketing in Europe.
Revenues for the quarter rose about 18 percent compared to revenues for the same quarter in 2014.
Following Covance's acquisition by LabCorp, NeoGenomics will no longer be an exclusive testing services partner but will receive a $2 million payment.
By buying Clarient, NeoGenomics hopes to move closer to its goal of becoming America's top cancer genetic testing lab.
The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.
In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.
Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.
Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.